Podymova S D, Bueverov A O, Nadinskaia M Iu
Ter Arkh. 1995;67(6):45-7.
A course of hepamerz treatment (7 intravenous drip infusions followed by oral administration for 14 days) was tried in 14 patients with hepatic cirrhosis to clarify hepamerz effects on hepatic encephalopathy and hyperammonemia which were judged by blood ammonium levels and time of psychomotor tests. All the patients responded. Fasting ammonium levels reduced in 67%, after meal in 82% of patients, 68% improved their psychomotor parameters. Transient nausea as a side effect occurred in 3 patients.
对14例肝硬化患者进行了一个疗程的肝美乐治疗（7次静脉滴注，随后口服给药14天），以通过血氨水平和精神运动测试时间来阐明肝美乐对肝性脑病和高氨血症的影响。所有患者均有反应。67%的患者空腹血氨水平降低，82%的患者餐后血氨水平降低，68%的患者精神运动参数得到改善。3例患者出现短暂恶心的副作用。
